A neurodegenerative perspective on mitochondrial optic neuropathies
Open accessThe DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Mitochondrial optic neuropathies constitute an important cause of chronic visual morbidity and registrable blindness in both the paediatric and adult population. It is a genetically heterogeneous group of disorders caused by both mitochondrial DNA (mtDNA) mutations and a growing list of nuclear genetic defects that invariably affect a critical component of the mitochondrial machinery. The two classical paradigms are Leber hereditary optic neuropathy (LHON), which is a primary mtDNA disorder, and autosomal dominant optic atrophy (DOA) secondary to pathogenic mutations within the nuclear gene OPA1 that encodes for a mitochondrial inner membrane protein. The defining neuropathological feature is the preferential loss of retinal ganglion cells (RGCs) within the inner retina but, rather strikingly, the smaller calibre RGCs that constitute the papillomacular bundle are particularly vulnerable, whereas melanopsin-containing RGCs are relatively spared. Although the majority of patients with LHON and DOA will present with isolated optic nerve involvement, some individuals will also develop additional neurological complications pointing towards a greater vulnerability of the central nervous system (CNS) in susceptible mutation carriers. These so-called "plus" phenotypes are mechanistically important as they put the loss of RGCs within the broader perspective of neuronal loss and mitochondrial dysfunction, highlighting common pathways that could be modulated to halt progressive neurodegeneration in other related CNS disorders. The management of patients with mitochondrial optic neuropathies still remains largely supportive, but the development of effective disease-modifying treatments is now within tantalising reach helped by major advances in drug discovery and delivery, and targeted genetic manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 LHON-MS overlap syndrome. T2 MRI images from a 27-year-old woman with episodes of recurrent optic neuritis over a 10-year period associated with partial visual recovery. There are disseminated high-signal changes within the white matter regions of the brain and cervical spinal cord that are consistent with demyelination [105]](https://figures.cochat.ai/paper-figures/21040ea5b7d6449ab0f37b733fbc8126/a-neurodegenerative-perspective-on-mitochondrial-optic-neuropathies-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The m.11778G>A mutation is the most common LHON mutation, accounting for about 70% of LHON in North America and Europe.1,3,4”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately 90% of all LHON cases are caused by one of three point mutations in the mtDNA: m.3460G>A in MT-ND1, m.11778G>A in MT-ND4 and m.14484T>C in MT-ND6.4”
From Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy (2023) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440 · cited 1×
“11778G>A LHON mutation was the first mtDNA variant linked with human disease and despite three decades of intensive research, there are still several unsolved mysteries, in particular the marked incomplete penetrance and the sex bias associated with this mitochondrial disorder [134].”
BackgroundThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179 · cited 13×
“The overlap between LHON and a multiple sclerosis (MS)-like illness (Harding disease) is a fascinating association that highlights a potential final common pathway linking mitochondrial dysfunction with neuronal loss and disease progression in acquired demyelinating disorders affecting the central nervous system (CNS).”
BackgroundInfluentialMutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446 · cited 1×
“1 3 encodes for a mitochondrial inner membrane protein with multifunctional properties [4, 47].”
BackgroundAlexander, C., Votruba, M., Pesch, U. E. A., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000) · Nature Genetics · doi:10.1038/79944 · Cited by 1,330
Self-citationPrevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease
Gorman, G. S., Schaefer, A. M., Ng, Y., Gomez, N., Blakely, E. L., Alston, C. L., Feeney, C., Horvath, R., Yu‐Wai‐Man, P., Chinnery, P. F., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24362 · Cited by 936 · cited 1×
“Mitochondrial diseases affect at least 1 in 4300 of the population and patients can present with either isolated or multisystemic organ involvement [58].”
BackgroundSelf-citationMitochondrial dysfunction as a cause of optic neuropathies
Carelli, V., Ross-Cisneros, F. N., & Sadun, A. A. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.003 · Cited by 839 · cited 4×
“14459G>A) in isolated families from Holland, Australia and North America have previously been linked with particularly severe LHON “plus” phenotypes complicated by spastic dystonia, ataxia, juvenile-onset encephalopathy, and psychiatric disturbances [35, 143].”
BackgroundInfluentialSelf-citationA Lethal Defect of Mitochondrial and Peroxisomal Fission
Waterham, H. R., Koster, J., van Roermund, C. W. T., Mooyer, P. A. W., Wanders, R. J. A., & Leonard, J. V. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064436 · Cited by 749 · cited 1×
“Interestingly, DRP1 is also a pro-fission cytosolic protein that is recruited to the mitochondrial outer membrane, and both SPG7 and AFG3L2 encode for mitochondrial AAA proteases that operate as oligomeric complexes to regulate the post-translational processing of OPA1 [39, 78, 135].”
BackgroundRoemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716 · cited 1×
“After decades of debate, clinicopathological studies have revealed striking differences between NMO and prototypic MS firmly establishing the two of them as distinct disease entities [23, 95, 113].”
ResultDisturbed mitochondrial dynamics and neurodegenerative disorders
Burté, F., Carelli, V., Chinnery, P. F., & Yu-Wai-Man, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.228 · Cited by 660 · cited 16×
“Rather strikingly, with the exception of WFS1, which encodes for an endoplasmic reticulum protein, all proteins associated with DOA are closely involved in regulating mitochondrial dynamics, pointing towards a key biological pathway essential for RGC maintenance and survival (Table 1) [28, 110].”
BackgroundInfluentialSelf-citationMitochondrial optic neuropathies—Disease mechanisms and therapeutic strategies
Yu-Wai-Man, P., Griffiths, P. G., & Chinnery, P. F. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.11.002 · Cited by 633 · cited 5×
“1 3 ocular complications, in particular involvement of the optic nerve [35, 143].”
BackgroundInfluentialSelf-citationLoss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Misu, T., Fujihara, K., Kakita, A., Konno, H., Nakamura, M., Watanabe, S., Takahashi, T., Nakashima, I., Takahashi, H., & Itoyama, Y. (2007) · Brain · doi:10.1093/brain/awm047 · Cited by 614 · cited 1×
“After decades of debate, clinicopathological studies have revealed striking differences between NMO and prototypic MS firmly establishing the two of them as distinct disease entities [23, 95, 113].”
ResultA randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy.
Klopstock, T., Yu-Wai-Man, P., Dimitriadis, K., Rouleau, J., Heck, S., Bailie, M., Atawan, A., Chattopadhyay, S., Schubert, M., Garip, A., et al. (2011) · Brain · doi:10.1093/brain/awr170 · Cited by 578 · cited 1×
“There is supporting evidence that idebenone can improve the visual prognosis, albeit, partially, in a subgroup of patients that are treated relatively early in the acute stage of LHON [33, 79, 80].”
BackgroundSelf-citationMitochondrial gene replacement in primate offspring and embryonic stem cells
Tachibana, M., Sparman, M., Sritanaudomchai, H., Ma, H., Clepper, L., Woodward, J., Li, Y., Ramsey, C., Kolotushkina, O., & Mitalipov, S. (2009) · Nature · doi:10.1038/nature08368 · Cited by 573 · cited 1×
“Pronuclear transfer and metaphase II spindle transfer are the two techniques that are currently being refined and further experimental work will hopefully validate the safety of these potentially groundbreaking mitochondrial replacement strategies [43, 67, 127, 128].”
BackgroundQuality control of mitochondria: protection against neurodegeneration and ageing
Tatsuta, T., & Langer, T. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601972 · Cited by 523 · cited 1×
“Other cellular mechanisms that have gained increasing attention in the context of mitochondrial optic neuropathies are mtDNA maintenance and mitophagy, and the cross-talk with the endoplasmic reticulum at MAM interfaces [28, 129].”
BackgroundOPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes
Amati-Bonneau, P., Valentino, M. L., Reynier, P., Gallardo, M. E., Bornstein, B., Boissiere, A., Campos, Y., Rivera, H., de la Aleja, J. G., Carroccia, R., et al. (2008) · Brain · doi:10.1093/brain/awm298 · Cited by 520 · cited 1×
“The clinical manifestations observed in OPA1 disease have now expanded further to include chronic progressive external ophthalmoplegia (CPEO) and other extraocular features such as ataxia, myopathy and peripheral neuropathy [7, 13, 65].”
BackgroundSelf-citationThe Epidemiology of Leber Hereditary Optic Neuropathy in the North East of England
Man, P. Y. W., Griffiths, P. G., Brown, D. T., Howell, N., Turnbull, D. M., & Chinnery, P. F. (2003) · The American Journal of Human Genetics · doi:10.1086/346066 · Cited by 483
Self-citationPronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease
Craven, L., Tuppen, H. A., Greggains, G. D., Harbottle, S. J., Murphy, J. L., Cree, L. M., Murdoch, A. P., Chinnery, P. F., Taylor, R. W., Lightowlers, R. N., et al. (2010) · Nature · doi:10.1038/nature08958 · Cited by 480 · cited 1×
“Pronuclear transfer and metaphase II spindle transfer are the two techniques that are currently being refined and further experimental work will hopefully validate the safety of these potentially groundbreaking mitochondrial replacement strategies [43, 67, 127, 128].”
BackgroundStrom, T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2021 · Cited by 478 · cited 1×
“Other genes associated with both isolated and syndromic forms of recessive optic atrophy include: (1) ACO2, which encodes for an enzyme of the tricarboxylic acid cycle [93]; (2) RTN4IP1, which encodes for a mitochondrial outer membrane protein that interacts with the endoplasmic reticulum protein RTN4 (or NOGO) to reg…”
BackgroundMulti-system neurological disease is common in patients with OPA1 mutations
Yu-Wai-Man, P., Griffiths, P. G., Gorman, G. S., Lourenco, C. M., Wright, A. F., Auer-Grumbach, M., Toscano, A., Musumeci, O., Valentino, M. L., Caporali, L., et al. (2010) · Brain · doi:10.1093/brain/awq007 · Cited by 450 · cited 3×
“Rather unexpectedly, analysis of muscle biopsies obtained from this group of patients revealed multiple mtDNA deletions and the presence of high levels of cytochrome c oxidase (COX)-deficient muscle fibres, some of which had marked mitochondrial proliferation in the form of ragged-red fibres [125, 144].”
BackgroundSelf-citationDavies, V. J., Hollins, A. J., Piechota, M. J., Yip, W., Davies, J. R., White, K. E., Nicols, P. P., Boulton, M. E., & Votruba, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm079 · Cited by 449 · cited 1×
“Heterozygous Opa1+/− mutant mice recapitulate the progressive RGC loss and optic nerve degeneration observed in the human form of the disease and the experimental data indicate that multiple pathways are involved that contribute to impaired mitochondrial oxidative phosphorylation, disturbed mitochondrial dynamics, inc…”
BackgroundSelf-citationHudson, G., Amati-Bonneau, P., Blakely, E. L., Stewart, J. D., He, L., Schaefer, A. M., Griffiths, P. G., Ahlqvist, K., Suomalainen, A., Reynier, P., et al. (2008) · Brain · doi:10.1093/brain/awm272 · Cited by 428
Towards germline gene therapy of inherited mitochondrial diseases
Tachibana, M., Amato, P., Sparman, M., Woodward, J., Sanchis, D. M., Ma, H., Gutierrez, N. M., Tippner-Hedges, R., Kang, E., Lee, H.-S., et al. (2013) · Nature · doi:10.1038/nature11647 · Cited by 426 · cited 1×
“Pronuclear transfer and metaphase II spindle transfer are the two techniques that are currently being refined and further experimental work will hopefully validate the safety of these potentially groundbreaking mitochondrial replacement strategies [43, 67, 127, 128].”
BackgroundMitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
Newman, N. J., Lott, M. T., & Wallace, D. C. (1991) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76784-4 · Cited by 403 · cited 1×
“Spontaneous visual recovery can occur, usually in the first year, but the prognosis remains guarded with most patients remaining within the legal criteria for blind registration [97].”
BackgroundUniversal heteroplasmy of human mitochondrial DNA
Payne, B. A. I., Wilson, I. J., Yu-Wai-Man, P., Coxhead, J., Deehan, D., Horvath, R., Taylor, R. W., Samuels, D. C., Santibanez-Koref, M., & Chinnery, P. F. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds435 · Cited by 395 · cited 2×
“Another possible explanation for the clonal expansion of somatic mtDNA deletions is the inability to remove these dysfunctional mtDNA species through mitophagy [34, 102].”
BackgroundSelf-citationHARDING, A. E., SWEENEY, M. G., MILLER, D. H., MUMFORD, C. J., KELLAR-WOOD, H., MENARD, D., MCDONALD, W. I., & COMPSTON, D. A. S. (1992) · Brain · doi:10.1093/brain/115.4.979 · Cited by 391
Gene–environment interactions in Leber hereditary optic neuropathy
Kirkman, M. A., Yu-Wai-Man, P., Korsten, A., Leonhardt, M., Dimitriadis, K., De Coo, I. F., Klopstock, T., & Chinnery, P. F. (2009) · Brain · doi:10.1093/brain/awp158 · Cited by 359
Self-citationAxonal neuropathy with optic atrophy is caused by mutations in mitofusin 2
Züchner, S., De Jonghe, P., Jordanova, A., Claeys, K. G., Guergueltcheva, V., Cherninkova, S., Hamilton, S. R., Van Stavern, G., Krajewski, K. M., Stajich, J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20797 · Cited by 358
Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease
Hyslop, L. A., Blakeley, P., Craven, L., Richardson, J., Fogarty, N. M. E., Fragouli, E., Lamb, M., Wamaitha, S. E., Prathalingam, N., Zhang, Q., et al. (2016) · Nature · doi:10.1038/nature18303 · Cited by 343 · cited 1×
“Pronuclear transfer and metaphase II spindle transfer are the two techniques that are currently being refined and further experimental work will hopefully validate the safety of these potentially groundbreaking mitochondrial replacement strategies [43, 67, 127, 128].”
BackgroundAlavi, M. V., Bette, S., Schimpf, S., Schuettauf, F., Schraermeyer, U., Wehrl, H. F., Ruttiger, L., Beck, S. C., Tonagel, F., Pichler, B. J., et al. (2006) · Brain · doi:10.1093/brain/awm005 · Cited by 282 · cited 1×
“Heterozygous Opa1+/− mutant mice recapitulate the progressive RGC loss and optic nerve degeneration observed in the human form of the disease and the experimental data indicate that multiple pathways are involved that contribute to impaired mitochondrial oxidative phosphorylation, disturbed mitochondrial dynamics, inc…”
BackgroundJin, H., May, M., Tranebjærg, L., Kendall, E., Fontán, G., Jackson, J., Subramony, S. H., Arena, F., Lubs, H., Smith, S., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-177 · Cited by 270 · cited 1×
“The Mohr-Tranebjaerg syndrome (deafness-dystoniaoptic atrophy) is associated with recessive mutations affecting the TIMM8A gene on the X-chromosome, which encodes for a translocase of the mitochondrial inner membrane (TIMM) [70].”
BackgroundLeber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy.
Nikoskelainen, E. K., Marttila, R. J., Huoponen, K., Juvonen, V, Lamminen, T., Sonninen, P., & Savontaus, M. L. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.2.160 · Cited by 270
Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies
Carelli, V (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00129-2 · Cited by 264 · cited 1×
“For LHON, histopathological studies of multiple tissues including the retina, optic nerve and brain are rare and none have been performed during the acute stage of the disease [36].”
BackgroundSelf-citationOestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy
Giordano, C., Montopoli, M., Perli, E., Orlandi, M., Fantin, M., Ross-Cisneros, F. N., Caparrotta, L., Martinuzzi, A., Ragazzi, E., Ghelli, A., et al. (2011) · Brain · doi:10.1093/brain/awq276 · Cited by 252 · cited 1×
“Oestrogens could also have a neuroprotective effect on RGCs and this feature could account, at least partly, for the relative protection of female LHON carriers against visual loss [55].”
BackgroundSelf-citationNeuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
Bennett, J., de Seze, J., Lana-Peixoto, M., Palace, J., Waldman, A., Schippling, S., Tenembaum, S., Banwell, B., Greenberg, B., Levy, M., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514567216 · Cited by 252 · cited 1×
“After decades of debate, clinicopathological studies have revealed striking differences between NMO and prototypic MS firmly establishing the two of them as distinct disease entities [23, 95, 113].”
ResultThe Neuro-ophthalmology of Mitochondrial Disease
Fraser, J. A., Biousse, V., & Newman, N. J. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.10.002 · Cited by 249 · cited 1×
“The defining neuropathological feature of LHON and DOA is the early loss of RGCs within the papillomacular bundle resulting in an expanding field defect, known as a scotoma, within the patient’s central vision [52].”
BackgroundBARBONI, P., SAVINI, G., VALENTINO, M., MONTAGNA, P., CORTELLI, P., DENEGRI, A., SADUN, F., BIANCHI, S., LONGANESI, L., & ZANINI, M. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.06.034 · Cited by 247 · cited 1×
“In vivo techniques such as magnetic resonance spectroscopy (MRS) and optical coherence tomography (OCT) are non-invasive and well tolerated, and they provide standardised tools that have been used to document the chronology and pattern of tissue loss in both the acute and chronic stages of LHON [19, 21, 121].”
MethodSelf-citationThe Distribution of Mitochondrial Activity in Relation to Optic Nerve Structure
Bristow, E. A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.791 · Cited by 243 · cited 1×
“The highly specialised anatomical and physiological properties of RGCs are likely to be relevant, namely their relatively high metabolic requirements due to sustained spiking activity; the constant exposure to potentially damaging light; the sharp 90-degree bend as their axons exit the eye at the lamina cribosa; and t…”
BackgroundThe MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype
Rouzier, C., Bannwarth, S., Chaussenot, A., Chevrollier, A., Verschueren, A., Bonello-Palot, N., Fragaki, K., Cano, A., Pouget, J., Pellissier, J.-F., et al. (2012) · Brain · doi:10.1093/brain/awr323 · Cited by 243
Idebenone Treatment In Leber's Hereditary Optic Neuropathy
Carelli, V., La Morgia, C., Valentino, M. L., Rizzo, G., Carbonelli, M., De Negri, A. M., Sadun, F., Carta, A., Guerriero, S., Simonelli, F., et al. (2011) · Brain · doi:10.1093/brain/awr180 · Cited by 241
Self-citationDavey, K. M., Parboosingh, J. S., McLeod, D. R., Chan, A., Casey, R., Ferreira, P., Snyder, F. F., Bridge, P. J., & Bernier, F. P. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036657 · Cited by 239 · cited 1×
“A similar mechanism of altered protein import through the mitochondrial inner membrane has also been postulated for the DCMA (dilated cardiomyopathy with ataxia) syndrome, which is caused by mutations in the DNAJC19 gene, and optic atrophy has been reported in some cases [45].”
BackgroundOPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution
Elachouri, G., Vidoni, S., Zanna, C., Pattyn, A., Boukhaddaoui, H., Gaget, K., Yu-Wai-Man, P., Gasparre, G., Sarzi, E., Delettre, C., et al. (2011) · Genome Research · doi:10.1101/gr.108696.110 · Cited by 238 · cited 1×
“The accumulation of somatic mtDNA deletions in post-mitotic tissues of patients carrying OPA1 mutations points towards an impaired mtDNA replication machinery and there is a suggestion that OPA1 could be part of the physical structure that anchors nucleoids to the mitochondrial inner membrane [48].”
BackgroundSelf-citationMouse mtDNA mutant model of Leber hereditary optic neuropathy
Lin, C. S., Sharpley, M. S., Fan, W., Waymire, K. G., Sadun, A. A., Carelli, V., Ross-Cisneros, F. N., Baciu, P., Sung, E., McManus, M. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217113109 · Cited by 228 · cited 9×
“In contrast to the widespread loss of RGCs in patients with LHON and DOA, an evolutionary ancient RGC subtype that expresses the photopigment melanopsin (mRGCs) seems relatively immune to mitochondrial dysfunction and impaired mitochondrial dynamics.”
BackgroundInfluentialSelf-citationOPA1 Mutation and Late‐Onset Cardiomyopathy: Mitochondrial Dysfunction and mtDNA Instability
Chen, L., Liu, T., Tran, A., Lu, X., Tomilov, A. A., Davies, V., Cortopassi, G., Chiamvimonvat, N., Bers, D. M., Votruba, M., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003012 · Cited by 223 · cited 2×
“In addition to inner retinal and optic nerve degeneration, more widespread neuropathological and psychophysical abnormalities have been noted in subgroups of Opa1+/− mutant mice, including enlarged lateral ventricles within the brain, disorganised myofibres in skeletal and cardiac muscle, locomotive and ataxic gait di…”
BackgroundSelf-citationEllouze, S., Augustin, S., Bouaita, A., Bonnet, C., Simonutti, M., Forster, V., Picaud, S., Sahel, J.-A., & Corral-Debrinski, M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.08.013 · Cited by 222 · cited 1×
“gov/ct2/home, accessed on 28 August 2016) [49, 61].”
Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy
Guy, J., Qi, X., Pallotti, F., Schon, E. A., Manfredi, G., Carelli, V., Martinuzzi, A., Hauswirth, W. W., & Lewin, A. S. (2002) · Annals of Neurology · doi:10.1002/ana.10354 · Cited by 215 · cited 1×
“gov/ct2/home, accessed on 28 August 2016) [49, 61].”
Self-citationBarboni, P., Carbonelli, M., Savini, G., Ramos, C. D. V. F., Carta, A., Berezovsky, A., Salomao, S. R., Carelli, V., & Sadun, A. A. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.07.026 · Cited by 215
Self-citationLeber’s hereditary optic neuropathy differentially affects smaller axons in the optic nerve
(2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00947-3 · Cited by 214 · cited 1×
“The acute phase of LHON is characterised by the early loss of RGCs within the papillomacular bundle and this interesting pathological feature has been ascribed to their smaller than average axonal calibre [118].”
BackgroundSelf-citationMutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder
Abrams, A. J., Hufnagel, R. B., Rebelo, A., Zanna, C., Patel, N., Gonzalez, M. A., Campeanu, I. J., Griffin, L. B., Groenewald, S., Strickland, A. V., et al. (2015) · Nature Genetics · doi:10.1038/ng.3354 · Cited by 206
Self-citationThe Prevalence and Natural History of Dominant Optic Atrophy Due to OPA1 Mutations
Yu-Wai-Man, P., Griffiths, P. G., Burke, A., Sellar, P. W., Clarke, M. P., Gnanaraj, L., Ah-Kine, D., Hudson, G., Czermin, B., Taylor, R. W., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.12.038 · Cited by 205 · cited 2×
“The natural history of the disease can also be highly variable with slowly progressive, sometimes step-like deterioration of visual function over time in most patients, whereas for others, visual acuity reaches a plateau in early to mid-adulthood without any further significant deterioration [41, 142].”
BackgroundSelf-citationJaner, A., Prudent, J., Paupe, V., Fahiminiya, S., Majewski, J., Sgarioto, N., Des Rosiers, C., Forest, A., Lin, Z., Gingras, A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506159 · Cited by 202
Hudson, G., Keers, S., Man, P. Y. W., Griffiths, P., Huoponen, K., Savontaus, M.-L., Nikoskelainen, E., Zeviani, M., Carrara, F., Horvath, R., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/498176 · Cited by 194 · cited 1×
“All the evidence so far points towards LHON being a complex disease that is determined by additional mitochondrial and nuclear genetic risk factors as well as environmental triggers such as smoking, which is associated with significantly increased risk of visual loss [66, 75, 88].”
BackgroundSelf-citationKjer, P. (1959) · PubMed · Cited by 194
La Morgia, C., Ross-Cisneros, F. N., Sadun, A. A., Hannibal, J., Munarini, A., Mantovani, V., Barboni, P., Cantalupo, G., Tozer, K. R., Sancisi, E., et al. (2010) · Brain · doi:10.1093/brain/awq155 · Cited by 193 · cited 1×
“Limited post-mortem studies of optic nerves from patients with LHON confirm that the neuropathology is limited to the RGC layer [82, 116].”
BackgroundSelf-citationHISTOPATHOLOGY OF EYE, OPTIC NERVE AND BRAIN IN A CASE OF DOMINANT OPTIC ATROPHY
KJER, P., JENSEN, O. A., & KLINKEN, L. (1983) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1983.tb01424.x · Cited by 192 · cited 1×
“As expected from the clinical features, post-mortem studies of optic nerves from patients with DOA confirmed the preferential loss of RGCs with evidence of axonal demyelination and gliosis [72, 77].”
BackgroundSyndromic parkinsonism and dementia associated with OPA 1 missense mutations
Carelli, V., Musumeci, O., Caporali, L., Zanna, C., La Morgia, C., Del Dotto, V., Porcelli, A. M., Rugolo, M., Valentino, M. L., Iommarini, L., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24410 · Cited by 191 · cited 2×
“Remarkably, two Italian families carrying different OPA1 missense mutations have been reported with an atypical combination of parkinsonism, dementia and CPEO, but with only subclinical optic neuropathy [34].”
BackgroundSelf-citationAnikster, Y., Kleta, R., Shaag, A., Gahl, W. A., & Elpeleg, O. (2001) · The American Journal of Human Genetics · doi:10.1086/324651 · Cited by 183 · cited 1×
“1 3 characterised by ataxia, spastic paraplegia, extrapyramidal dysfunction, cognitive deficits and optic atrophy, and it is almost exclusively seen in patients of Iraqi Jewish descent harbouring recessive OPA3 mutations [10].”
BackgroundA Clinicopathologic Study of Autosomal Dominant Optic Atrophy
Johnston, P. B., Gaster, R. N., Smith, V. C., & Tripathi, R. C. (1979) · American Journal of Ophthalmology · doi:10.1016/0002-9394(79)90565-8 · Cited by 180 · cited 1×
“As expected from the clinical features, post-mortem studies of optic nerves from patients with DOA confirmed the preferential loss of RGCs with evidence of axonal demyelination and gliosis [72, 77].”
BackgroundAge-related decline of human optic nerve axon populations
Johnson, B. M., Miao, M., & Sadun, A. A. (1987) · AGE · doi:10.1007/bf02431765 · Cited by 180 · cited 14×
“The overlap between LHON and a multiple sclerosis (MS)-like illness (Harding disease) is a fascinating association that highlights a potential final common pathway linking mitochondrial dysfunction with neuronal loss and disease progression in acquired demyelinating disorders affecting the central nervous system (CNS).”
BackgroundInfluentialOPA1 R445H mutation in optic atrophy associated with sensorineural deafness
Amati‐Bonneau, P., Guichet, A., Olichon, A., Chevrollier, A., Viala, F., Miot, S., Ayuso, C., Odent, S., Arrouet, C., Verny, C., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20681 · Cited by 176 · cited 1×
“Arg455His), has been consistently associated with sensorineural deafness in a number of families [6, 144].”
BackgroundPersistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy
Klopstock, T., Metz, G., Yu-Wai-Man, P., Büchner, B., Gallenmüller, C., Bailie, M., Nwali, N., Griffiths, P. G., von Livonius, B., Reznicek, L., et al. (2013) · Brain · doi:10.1093/brain/aws279 · Cited by 175
Self-citationPfeffer, G., Gorman, G. S., Griffin, H., Kurzawa-Akanbi, M., Blakely, E. L., Wilson, I., Sitarz, K., Moore, D., Murphy, J. L., Alston, C. L., et al. (2014) · Brain · doi:10.1093/brain/awu060 · Cited by 175
Self-citationSpastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy
Klebe, S., Depienne, C., Gerber, S., Challe, G., Anheim, M., Charles, P., Fedirko, E., Lejeune, E., Cottineau, J., Brusco, A., et al. (2012) · Brain · doi:10.1093/brain/aws240 · Cited by 173
Sadun, A. A. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2972 · Cited by 172 · cited 1×
“EPI-743 has also shown promise in a small case series of five patients with acute LHON treated within 90 days of disease conversion, but a randomised placebo-controlled trial is needed to fully explore its true therapeutic potential [117].”
BackgroundSelf-citationVisual system involvement in patients with Friedreich's ataxia
Fortuna, F., Barboni, P., Liguori, R., Valentino, M. L., Savini, G., Gellera, C., Mariotti, C., Rizzo, G., Tonon, C., Manners, D., et al. (2009) · Brain · doi:10.1093/brain/awn269 · Cited by 171
Self-citationHistochemical localisation of mitochondrial enzyme activity in human optic nerve and retina
Andrews, R. M., Griffiths, P. G., Johnson, M. A., & Turnbull, D. M. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.2.231 · Cited by 167 · cited 1×
“The highly specialised anatomical and physiological properties of RGCs are likely to be relevant, namely their relatively high metabolic requirements due to sustained spiking activity; the constant exposure to potentially damaging light; the sharp 90-degree bend as their axons exit the eye at the lamina cribosa; and t…”
BackgroundNew treatments for mitochondrial disease—no time to drop our standards
Pfeffer, G., Horvath, R., Klopstock, T., Mootha, V. K., Suomalainen, A., Koene, S., Hirano, M., Zeviani, M., Bindoff, L. A., Yu-Wai-Man, P., et al. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.129 · Cited by 167 · cited 3×
“1 3 manifestations of LHON and DOA deserve to be studied further [106, 148].”
BackgroundInfluentialSelf-citationFerré, M., Bonneau, D., Milea, D., Chevrollier, A., Verny, C., Dollfus, H., Ayuso, C., Defoort, S., Vignal, C., Zanlonghi, X., et al. (2009) · Human Mutation · doi:10.1002/humu.21025 · Cited by 165 · cited 1×
“Over 250 OPA1 mutations have been reported and these can be grouped into two major categories depending on whether they are predicted to cause disease due to haploinsufficiency (deletions, insertions, splice site and nonsense mutations) or a possible dominant-negative mechanism (missense mutations) [50, 53].”
BackgroundOPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract
Reynier, P., Amati-Bonneau, P., Verny, C., Olichon, A., Simard, G., Guichet, A., Bonnemains, C., Malecaze, F., Malinge, M. C., Pelletier, J. B., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.016576 · Cited by 160 · cited 1×
“More recently, heterozygous mutations in a number of nuclear genes have been identified in patients with DOA, including dominant OPA3 mutations in families segregating optic atrophy and early onset cataracts [111].”
BackgroundMutations in C12orf65 in Patients with Encephalomyopathy and a Mitochondrial Translation Defect
Antonicka, H., Østergaard, E., Sasarman, F., Weraarpachai, W., Wibrand, F., Pedersen, A. M. B., Rodenburg, R. J., van der Knaap, M. S., Smeitink, J. A. M., Chrzanowska-Lightowlers, Z. M., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.06.004 · Cited by 159 · cited 1×
“It should also be noted that both SLC25A46 and C12orf65 mutations can also result in a much more severe neurodegenerative Leigh-like presentation [11, 64, 69].”
BackgroundSavini, G., Barboni, P., Valentino, M. L., Montagna, P., Cortelli, P., DeNegri, A. M., Sadun, F., BIANCHI, S., Longanesi, L., Zanini, M., et al. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.09.033 · Cited by 153 · cited 1×
“In vivo techniques such as magnetic resonance spectroscopy (MRS) and optical coherence tomography (OCT) are non-invasive and well tolerated, and they provide standardised tools that have been used to document the chronology and pattern of tissue loss in both the acute and chronic stages of LHON [19, 21, 121].”
MethodSelf-citationTreatment strategies for inherited optic neuropathies: past, present and future
Yu‐Wai‐Man, P., Votruba, M., Moore, A. T., & Chinnery, P. F. (2014) · Eye · doi:10.1038/eye.2014.37 · Cited by 151
Self-citationMitochondrial DNA: Impacting Central and Peripheral Nervous Systems
Carelli, V., & Chan, D. C. (2014) · Neuron · doi:10.1016/j.neuron.2014.11.022 · Cited by 145 · cited 2×
“They must be able to cluster at synapses to deliver sufficient quantities of ATP locally and altering the delicate balance between mitochondrial fusion and fission is essential to meet the cell’s fluctuating bioenergetic demands, in addition to supporting bidirectional transport along dendrites and axon [31].”
BackgroundSelf-citationWiley, S. E., Andreyev, A. Y., Divakaruni, A. S., Karisch, R., Perkins, G. A., Wall, E. A., van der Geer, P., Chen, Y., Tsai, T., Simon, M. I., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201429 · Cited by 139 · cited 1×
“Other genes associated with both isolated and syndromic forms of recessive optic atrophy include: (1) ACO2, which encodes for an enzyme of the tricarboxylic acid cycle [93]; (2) RTN4IP1, which encodes for a mitochondrial outer membrane protein that interacts with the endoplasmic reticulum protein RTN4 (or NOGO) to reg…”
BackgroundAutosomal Dominant Optic Atrophy: Penetrance and Expressivity in Patients With OPA1 Mutations
Cohn, A., Toomes, C., Potter, C., Towns, K. V., Hewitt, A. W., Inglehearn, C. F., Craig, J. E., & Mackey, D. A. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.12.038 · Cited by 136 · cited 1×
“Some mutation carriers present with very poor visual function from birth with optic nerve hypoplasia, whereas others are visually asymptomatic and they are only detected as part of familial contact tracing [15, 42].”
BackgroundThe human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse
Sarzi, E., Angebault, C., Seveno, M., Guéguen, N., Chaix, B., Biélicki, G., Boddaert, N., Mausset-Bonnefont, A.-L., Cazevieille, C., Rigau, V., et al. (2012) · Brain · doi:10.1093/brain/aws303 · Cited by 130
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica
Gelfand, J. M., Cree, B., Nolan, R. C., Arnow, S., & Green, A. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1832 · Cited by 130 · cited 1×
“Similar microcystic macular changes have previously been described in patients with demyelinating optic neuritis and a possible aetiological link was made with the severity of the underlying inflammatory process [54].”
BackgroundRendtorff, N. D., Lodahl, M., Boulahbel, H., Johansen, I. R., Pandya, A., Welch, K. O., Norris, V. W., ARNOS, K. S., Bitner-Glindzicz, M. A. K., Emery, S. B., et al. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33970 · Cited by 129
Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations
Pfeffer, G., Burke, A., Yu-Wai-Man, P., Compston, D. A. S., & Chinnery, P. F. (2013) · Neurology · doi:10.1212/01.wnl.0000437308.22603.43 · Cited by 122 · cited 1×
“The pattern of visual loss in LHONMS appears distinct from classical LHON and demyelinating optic neuritis, being marked by recurrent episodes of visual loss that can be associated with ocular pain, but with incomplete visual recovery and progression to registrable blindness in half of all patients [104].”
BackgroundSelf-citationMathematically Modeling the Involvement of Axons in Leber's Hereditary Optic Neuropathy
Pan, B. X., Ross-Cisneros, F. N., Carelli, V., Rue, K. S., Salomao, S. R., Moraes-Filho, M. N., Moraes, M. N., Berezovsky, A., Belfort, R., & Sadun, A. A. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10452 · Cited by 120 · cited 1×
“The basis for this anatomical vulnerability has been modelled using a mathematical equation that integrates the surface area (energy demand) and volume (energy supply) ratio of the RGC axons, in relation to the amount of ATP needed to maintain axonal conduction [101].”
MethodSelf-citationSpiegel, R., Saada, A., Flannery, P. J., Burté, F., Soiferman, D., Khayat, M., Eisner, V., Vladovski, E., Taylor, R. W., Bindoff, L. A., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103361 · Cited by 117 · cited 1×
“More recently, a compound homozygous OPA1 mutation has been identified for the first time in two affected Jewish sisters from consanguineous parents who developed a fatal infantile encephalomyopathy with hypertrophic cardiomyopathy and optic atrophy [123].”
BackgroundSelf-citationQuality of Life in Patients with Leber Hereditary Optic Neuropathy
Kirkman, M. A., Korsten, A., Leonhardt, M., Dimitriadis, K., de Coo, I. F. M., Klopstock, T., Griffiths, P. G., Hudson, G., Chinnery, P. F., & Yu‐Wai‐Man, P. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3166 · Cited by 117 · cited 1×
“Unsurprisingly, the risk of blindness ranks high on patients’ fears about the prognosis associated with their specific mitochondrial genetic defect [12, 74].”
BackgroundSelf-citationBarboni, P., Carelli, V., Savini, G., Carbonelli, M., Morgia, C. L., & Sadun, A. A. (2013) · Brain · doi:10.1093/brain/awt014 · Cited by 113 · cited 9×
“In contrast to the widespread loss of RGCs in patients with LHON and DOA, an evolutionary ancient RGC subtype that expresses the photopigment melanopsin (mRGCs) seems relatively immune to mitochondrial dysfunction and impaired mitochondrial dynamics.”
BackgroundInfluentialSelf-citationNeuropathology of white matter disease in Leber's hereditary optic neuropathy
Kovács, G. G., Höftberger, R., Majtényi, K., Horváth, R., Barsi, P., Komoly, S., Lassmann, H., Budka, H., & Jakab, G. (2004) · Brain · doi:10.1093/brain/awh310 · Cited by 112 · cited 14×
“The overlap between LHON and a multiple sclerosis (MS)-like illness (Harding disease) is a fascinating association that highlights a potential final common pathway linking mitochondrial dysfunction with neuronal loss and disease progression in acquired demyelinating disorders affecting the central nervous system (CNS).”
BackgroundInfluentialMacular nerve fibre and ganglion cell layer changes in acute Leber's hereditary optic neuropathy
Balducci, N., Savini, G., Cascavilla, M. L., Morgia, C. L., Triolo, G., Giglio, R., Carbonelli, M., Parisi, V., Sadun, A. A., Bandello, F. M., et al. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-307326 · Cited by 109 · cited 1×
“Maximal GC-IPL thinning was reached by 6 months and this OCT parameter could, therefore, prove to be a more sensitive biomarker of optic nerve damage compared with peripapillary RNFL measurements where progressive thinning continues until at least 12 months after the first onset of visual loss [14].”
BackgroundSelf-citationHanein, S., Perrault, I., Roche, O., Gerber, S., Khadom, N., Rio, M., Boddaert, N., Jeanpierre, M., Brahimi, N., Serre, V., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.003 · Cited by 106 · cited 1×
“TMEM126A, which encodes for a mitochondrial inner membrane protein of unclear function, was the first gene to be found in patients with non-syndromic recessive optic atrophy, although it can also occur in combination with peripheral neuropathy in some mutation carriers [62].”
BackgroundMoura, A. L. A., Nagy, B. V., Morgia, C. L., Barboni, P., Oliveira, A. G. F., Salomão, S. R., Berezovsky, A., Moraes-Filho, M. N., Chicani, C. F., Belfort, R., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11137 · Cited by 103
Self-citationOPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules
Yu‐Wai‐Man, P., Sitarz, K. S., Samuels, D. C., Griffiths, P. G., Reeve, A. K., Bindoff, L. A., Horváth, R., & Chinnery, P. F. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq209 · Cited by 101 · cited 1×
“The accumulation of mtDNA deletions is a fascinating observation that could be due to the accelerated clonal expansion of these somatic mutations to sufficiently high levels to trigger a biochemical COX defect [102, 146].”
BackgroundSelf-citationMetodiev, M. D., Gerber, S., Hubert, L., Delahodde, A., Chrétien, D., Gérard, X., Amati‐Bonneau, P., Giacomotto, M.-C., Boddaert, N., Kamińska, A., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102532 · Cited by 99 · cited 1×
“Other genes associated with both isolated and syndromic forms of recessive optic atrophy include: (1) ACO2, which encodes for an enzyme of the tricarboxylic acid cycle [93]; (2) RTN4IP1, which encodes for a mitochondrial outer membrane protein that interacts with the endoplasmic reticulum protein RTN4 (or NOGO) to reg…”
BackgroundOpa1 is essential for retinal ganglion cell synaptic architecture and connectivity
Williams, P. A., Piechota, M. J., von Ruhland, C., Taylor, E., Morgan, J. E., & Votruba, M. (2012) · Brain · doi:10.1093/brain/awr330 · Cited by 97
Self-citationThe epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom
Jacob, A., Panicker, J., Lythgoe, D. T., Elsone, L., Mutch, K., Wilson, M., Das, K., & Boggild, M. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6926-y · Cited by 97 · cited 1×
“1 3 with a prevalence that is 50–100 times lower than that of MS [68].”
BackgroundLHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation
Blakely, E. L., de Silva, R. N., King, A., Schwarzer, V., Harrower, T., Dawidek, G., Turnbull, D. M., & Taylor, R. W. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201363 · Cited by 96 · cited 1×
“3697G>A, with a pronounced inhibitory effect on complex I activity have also been identified in patients with an LHON-like optic neuropathy and features of the MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) syndrome [24, 124].”
BackgroundMitochondrial Donation — How Many Women Could Benefit?
Gorman, G. S., Grady, J. P., Ng, Y., Schaefer, A. M., McNally, R., Chinnery, P. F., Yu‐Wai‐Man, P., Herbert, M., Taylor, R. W., McFarland, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1500960 · Cited by 96 · cited 1×
“There is an estimated 2300 women of childbearing age in the United Kingdom that harbour pathogenic mtDNA mutations and by using the national fertility rate, about 150 newborn per year would be at high risk of developing severe mitochondrial disease [56].”
BackgroundSelf-citationEarly-onset Behr syndrome due to compound heterozygous mutations in OPA1
Bonneau, D., Colin, E., Oca, F., Ferré, M., Chevrollier, A., Guéguen, N., Desquiret‐Dumas, V., Tich, S. N. T., Barth, M., Zanlonghi, X., et al. (2014) · Brain · doi:10.1093/brain/awu184 · Cited by 94
The natural history of OPA1-related autosomal dominant optic atrophy
Cohn, A., Toomes, C., Hewitt, A. W., Kearns, L. S., Inglehearn, C. F., Craig, J. E., & Mackey, D. A. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.134726 · Cited by 86
Retinal Nerve Fiber Layer Thickness in Dominant Optic Atrophy
Barboni, P., Savini, G., Parisi, V., Carbonelli, M., Morgia, C. L., Maresca, A., Sadun, F., Negri, A. M. D., Carta, A., Sadun, A. A., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.02.027 · Cited by 86
Self-citationBonifert, T., Karle, K. N., Tonagel, F., Batra, M., Wilhelm, C., Theurer, Y., Schönfeld, C., Kluba, T., Kamenisch, Y., Carelli, V., et al. (2014) · Brain · doi:10.1093/brain/awu165 · Cited by 85
Self-citationMultiple sclerosis associated with Leber's Hereditary Optic Neuropathy
Palace, J. A. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.009 · Cited by 84
Homoplasmy, heteroplasmy, and mitochondrial dystonia
McFarland, R., Chinnery, P. F., Blakely, E. L., Schaefer, A. M., Morris, A. A. M., Foster, S. M., Tuppen, H. A. L., Ramesh, V., Dorman, P. J., Turnbull, D. M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000267843.10977.4a · Cited by 76 · cited 1×
“Dystonia and myoclonus are two movement disorders that have been consistently associated with the three primary LHON mutations and the development of these extraocular features clearly indicates the potential for a more generalised neurodegenerative process among at-risk LHON carriers [38, 92].”
BackgroundRecessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic Neuropathies
Angebault, C., Guichet, P., Talmat-Amar, Y., Charif, M., Gerber, S., Fares‐Taie, L., Guéguen, N., Halloy, F., Moore, D. G., Amati‐Bonneau, P., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.09.012 · Cited by 75 · cited 1×
“Other genes associated with both isolated and syndromic forms of recessive optic atrophy include: (1) ACO2, which encodes for an enzyme of the tricarboxylic acid cycle [93]; (2) RTN4IP1, which encodes for a mitochondrial outer membrane protein that interacts with the endoplasmic reticulum protein RTN4 (or NOGO) to reg…”
BackgroundSelf-citationPattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations
Yu‐Wai‐Man, P., Bailie, M., Atawan, A., Chinnery, P. F., & Griffiths, P. G. (2011) · Eye · doi:10.1038/eye.2011.2 · Cited by 75
Self-citationEpidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review
Pereira, W. L. D. C. J., Reiche, E. M. V., Kallaur, A. P., & Kaimen-Maciel, D. R. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.034 · Cited by 72 · cited 13×
“The overlap between LHON and a multiple sclerosis (MS)-like illness (Harding disease) is a fascinating association that highlights a potential final common pathway linking mitochondrial dysfunction with neuronal loss and disease progression in acquired demyelinating disorders affecting the central nervous system (CNS).”
BackgroundInfluentialEarly Macular Retinal Ganglion Cell Loss in Dominant Optic Atrophy: Genotype-Phenotype Correlation
Barboni, P., Savini, G., Cascavilla, M. L., Caporali, L., Milesi, J., Borrelli, E., Morgia, C. L., Valentino, M. L., Triolo, G., Lembo, A., et al. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.05.034 · Cited by 70
Self-citationMitochondrial DNA haplogroup distribution within Leber hereditary optic neuropathy pedigrees
Yu‐Wai‐Man, P., Howell, N., Mackey, D. A., Nørby, S., Rosenberg, T., Turnbull, D. M., & Chinnery, P. F. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.011247 · Cited by 67 · cited 1×
“All the evidence so far points towards LHON being a complex disease that is determined by additional mitochondrial and nuclear genetic risk factors as well as environmental triggers such as smoking, which is associated with significantly increased risk of visual loss [66, 75, 88].”
BackgroundSelf-citationOPA1 Mutations Associated with Dominant Optic Atrophy Influence Optic Nerve Head Size
Barboni, P., Carbonelli, M., Savini, G., Foscarini, B., Parisi, V., Valentino, M. L., Carta, A., Negri, A. M. D., Sadun, F., Zeviani, M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.12.042 · Cited by 66 · cited 1×
“Some mutation carriers present with very poor visual function from birth with optic nerve hypoplasia, whereas others are visually asymptomatic and they are only detected as part of familial contact tracing [15, 42].”
BackgroundSelf-citationSaadati, H. G. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.7.911 · Cited by 64 · cited 2×
“Limited post-mortem studies of optic nerves from patients with LHON confirm that the neuropathology is limited to the RGC layer [82, 116].”
BackgroundFURTHER CLINICAL AND PATHOLOGICAL OBSERVATIONS ON LEBER'S OPTIC ATROPHY
ADAMS, J. H., BLACKWOOD, W., & Wilson, J. (1966) · Brain · doi:10.1093/brain/89.1.15 · Cited by 64 · cited 1×
“The number of post-mortem studies for patients with mitochondrial optic neuropathies is limited and some historical reports date back to the pre-molecular era [2, 116].”
BackgroundMULTIPLE SCLEROSIS–LIKE DISORDER IN OPA1-RELATED AUTOSOMAL DOMINANT OPTIC ATROPHY
Verny, C., Loiseau, D., Scherer‐Gagou, C., Lejeune, P., Chevrollier, A., Guéguen, N., Guillet, V., Dubas, F., Reynier, P., Amati‐Bonneau, P., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000289194.89359.a1 · Cited by 63 · cited 1×
“Similar to Harding disease in LHON, OPA1 mutation carriers can also develop an MS-like illness where the optic atrophy occurs on the background of a more disseminated inflammatory process with neuroradiological and serological features, consistent with MS [133, 147].”
BackgroundA MELAS-Associated ND1 Mutation Causing Leber Hereditary Optic Neuropathy and Spastic Dystonia
Spruijt, L., Smeets, H. J. M., Hendrickx, A. T. M., Bettink‐Remeijer, M. W., Maat‐Kievit, A., Schoonderwoerd, K. C., Sluiter, W. J., de Coo, I. F. M., & Hintzen, R. Q. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.890 · Cited by 62 · cited 1×
“3697G>A, with a pronounced inhibitory effect on complex I activity have also been identified in patients with an LHON-like optic neuropathy and features of the MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) syndrome [24, 124].”
BackgroundLeber Hereditary Optic Neuropathy
Kerrison, J. B., Howell, N., Miller, N. R., Hirst, L. W., & Green, W. R. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30838-x · Cited by 62 · cited 1×
“Notwithstanding these practical limitations, there is severe loss of RGCs and marked thinning of the retinal nerve fibre layer (RNFL), but the remaining retinal structure is otherwise preserved [73, 119].”
BackgroundQi, X., Sun, L. T., Hauswirth, W. W., Lewin, A. S., & Guy, J. R. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.2.268 · Cited by 61
Mitochondrial DNA Defects and Selective Extraocular Muscle Involvement in CPEO
Greaves, L. C., Yu‐Wai‐Man, P., Blakely, E. L., Krishnan, K. J., Beadle, N. E., Kerin, J., Barron, M. J., Griffiths, P. G., Dickinson, A. J., Turnbull, D. M., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4659 · Cited by 60 · cited 1×
“1 3 of all patients with DOA plus phenotypes develop ptosis and ophthalmoplegia in later life [59, 145].”
BackgroundSelf-citation‘Behr syndrome’ with OPA1 compound heterozygote mutations
Carelli, V., Sabatelli, M., Carrozzo, R., Rizza, T., Schimpf, S., Wissinger, B., Zanna, C., Rugolo, M., La Morgia, C., Caporali, L., et al. (2015) · Brain · doi:10.1093/brain/awu234 · Cited by 60 · cited 1×
“The association of optic atrophy with spastic paraplegia, resembling cases that fit the historical description of Behr syndrome, has been well described in several unrelated OPA1 mutation carriers [26, 37, 90].”
BackgroundSelf-citationGenomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy
Fuhrmann, N., Alavi, M. V., Bitoun, P., Wornle, S., Auburger, G. W. J., Leo‐Kottler, B., Yu‐Wai‐Man, P., Chinnery, P. F., & Wissinger, B. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062570 · Cited by 59 · cited 1×
“Over 250 OPA1 mutations have been reported and these can be grouped into two major categories depending on whether they are predicted to cause disease due to haploinsufficiency (deletions, insertions, splice site and nonsense mutations) or a possible dominant-negative mechanism (missense mutations) [50, 53].”
BackgroundSelf-citationEvidence for retrochiasmatic tissue loss in Leber's hereditary optic neuropathy
Barcella, V., Rocca, M. A., Bianchi‐Marzoli, S., Milesi, J., Melzi, L., Falini, A., Pierro, L., & Filippi, M. (2010) · Human Brain Mapping · doi:10.1002/hbm.20985 · Cited by 57 · cited 1×
“MRI tractography studies indicate that the loss of RGCs in the anterior visual pathway could result in transsynaptic degeneration that extends from the lateral geniculate nucleus to the optic radiations, as reported previously in other optic neuropathies such as demyelinating optic neuritis and glaucoma [22, 89].”
BackgroundTranebjærg, L., Jensen, P. K. A., Ghelue, M. V., Vnencak‐Jones, C. L., Sund, S., Elgjo, K. M., Jakobsen, J., Lindal, S., Warburg, M., Fuglsang‐Frederiksen, A., et al. (2001) · Ophthalmic Genetics · doi:10.1076/opge.22.4.207.2220 · Cited by 55 · cited 1×
“Visual failure in this disorder is thought to be due to global involvement of the visual pathways, extending as far back as the visual cortex [130].”
BackgroundAlavi, M. V., Fuhrmann, N., Nguyen, H. P., Yu‐Wai‐Man, P., Heiduschka, P., Chinnery, P. F., & Wissinger, B. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.026 · Cited by 54 · cited 2×
“1 3 encodes for a mitochondrial inner membrane protein with multifunctional properties [4, 47].”
BackgroundSelf-citationSomatic Mitochondrial DNA Deletions Accumulate to High Levels in Aging Human Extraocular Muscles
Yu‐Wai‐Man, P., Lai‐Cheong, J. E., Borthwick, G. M., He, L., Taylor, G. A., Greaves, L. C., Taylor, R. W., Griffiths, P. G., & Turnbull, D. M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4660 · Cited by 54 · cited 1×
“1 3 of all patients with DOA plus phenotypes develop ptosis and ophthalmoplegia in later life [59, 145].”
BackgroundSelf-citationMFN2, a new gene responsible for mitochondrial DNA depletion
Renaldo, F., Amati‐Bonneau, P., Slama, A., Romana, C., Forin, V., Doummar, D., Barnérias, C., Bursztyn, J., Mayer, M., Khouri, N., et al. (2012) · Brain · doi:10.1093/brain/aws111 · Cited by 53
Charif, M., Roubertie, A., Salime, S., Mamouni, S., Goizet, C., Hamel, C., & Lenaers, G. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00311 · Cited by 51 · cited 1×
“Interestingly, DRP1 is also a pro-fission cytosolic protein that is recruited to the mitochondrial outer membrane, and both SPG7 and AFG3L2 encode for mitochondrial AAA proteases that operate as oligomeric complexes to regulate the post-translational processing of OPA1 [39, 78, 135].”
BackgroundThe mitochondrial brain: From mitochondrial genome to neurodegeneration
Turnbull, H. E., Lax, N. Z., Diodato, D., Ansorge, O., & Turnbull, D. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.010 · Cited by 49 · cited 1×
“In terms of their clinical relevance, the neuroradiological changes observed in patients with mitochondrial optic neuropathies could prove useful surrogate biomarkers for the spectrum of white matter neuropathological abnormalities observed in mitochondrial disease, which can range from mild atrophy to extensive vacuo…”
BackgroundLeber Hereditary Optic Neuropathy Mimicking Neuromyelitis Optica
McClelland, C. M., Stavern, G. P. V., & Tselis, A. C. (2011) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e318225247b · Cited by 48 · cited 3×
“It is, therefore, interesting that in addition to Harding disease, patients with LHON have been described who developed a prominent spinal cord syndrome mimicking the radiological and pathological features of NMO [91, 122].”
BackgroundHeterozygous OPA1 mutations in Behr syndrome
Marelli, C., Amati‐Bonneau, P., Reynier, P., Layet, V., Layet, A., Stévanin, G., Brissaud, E., Bonneau, D., Dürr, A., & Brice, A. (2010) · Brain · doi:10.1093/brain/awq306 · Cited by 46
Genetic manipulation for inherited neurodegenerative diseases: myth or reality?
Yu‐Wai‐Man, P. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-308329 · Cited by 45 · cited 2×
“The coming decade will bring together a confluence of major advances in cell-based and genomic editing technologies that hold the potential to revolutionise our approach to the prevention and treatment of human genetic diseases [139].”
BackgroundSelf-citationGorman, G. S., Pfeffer, G., Griffin, H. R., Blakely, E. L., Kurzawa‐Akanbi, M., Gabriel, J., Sitarz, K. S., Roberts, M., Schoser, B. G. H., Pyle, A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1753 · Cited by 45 · cited 1×
“MtDNA maintenance is clearly intrinsically linked to the delicate balance between mitochondrial fusion and fission and adding further weight to this hypothesis, SPG7 and AFG3L2 mutations have now been reported in patients with ataxic disorders complicated by CPEO and optic atrophy, and with evidence of multiple mtDNA…”
BackgroundRetinal Nerve Fiber Layer Thickness Variability in Leber Hereditary Optic Neuropathy Carriers
Barboni, P., Savini, G., Feuer, W. J., Budenz, D. L., Carbonelli, M., Chicani, F., Ramos, C. D. V. F., Salomao, S. R., De Negri, A., Parisi, V., et al. (2012) · European Journal of Ophthalmology · doi:10.5301/ejo.5000154 · Cited by 42 · cited 1×
“In vivo techniques such as magnetic resonance spectroscopy (MRS) and optical coherence tomography (OCT) are non-invasive and well tolerated, and they provide standardised tools that have been used to document the chronology and pattern of tissue loss in both the acute and chronic stages of LHON [19, 21, 121].”
MethodSelf-citationA multiple sclerosis‐like disorder in patients with OPA1 mutations
Yu‐Wai‐Man, P., Spyropoulos, A., Duncan, H., Guadagno, J. V., & Chinnery, P. F. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.323 · Cited by 40
Self-citationCarbonelli, M., Morgia, C. L., Savini, G., Cascavilla, M. L., Borrelli, E., Chicani, F., Ramos, C. D. V. F., Salomão, S. R., Parisi, V., Sebag, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127906 · Cited by 37 · cited 9×
“In contrast to the widespread loss of RGCs in patients with LHON and DOA, an evolutionary ancient RGC subtype that expresses the photopigment melanopsin (mRGCs) seems relatively immune to mitochondrial dysfunction and impaired mitochondrial dynamics.”
BackgroundInfluentialSelf-citationLeber's hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases
Carelli, V., Valentino, M. L., Liguori, R., Meletti, S., Vetrugno, R., Provini, F., Mancardi, G. L., Bandini, F., Baruzzi, A., & Montagna, P. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.6.813 · Cited by 34 · cited 1×
“Dystonia and myoclonus are two movement disorders that have been consistently associated with the three primary LHON mutations and the development of these extraocular features clearly indicates the potential for a more generalised neurodegenerative process among at-risk LHON carriers [38, 92].”
BackgroundSelf-citationLamination of the Outer Plexiform Layer in Optic Atrophy Caused by Dominant WFS1 Mutations
Majander, A. S., Bitner-Glindzicz, M. A. K., Chan, C. M., Duncan, H., Chinnery, P. F., Subash, M., Keane, P. A., Webster, A. R., Moore, A. T., Michaelides, M., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.007 · Cited by 34
Self-citationOPA1 IN MULTIPLE MITOCHONDRIAL DNA DELETION DISORDERS
Stewart, J. D., Hudson, G., Yu‐Wai‐Man, P., Blakeley, E. L., He, L., Horváth, R., Maddison, P., Wright, A. F., Griffiths, P. G., Turnbull, D. M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000335931.54095.0a · Cited by 31 · cited 1×
“Rather unexpectedly, analysis of muscle biopsies obtained from this group of patients revealed multiple mtDNA deletions and the presence of high levels of cytochrome c oxidase (COX)-deficient muscle fibres, some of which had marked mitochondrial proliferation in the form of ragged-red fibres [125, 144].”
BackgroundSelf-citationPyle, A., Ramesh, V., Bartsakoulia, M., Boczonadi, V., Gómez-Durán, A., Herczegfalvi, Á., Blakely, E. L., Smertenko, T., Duff, J., Eglon, G., et al. (2014) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-140003 · Cited by 31 · cited 2×
“Prompted by this phenotypic association, other inherited forms of optic atrophy associated with CMT disease have been recently described with recessive mutations in SLC25A46 [1] and C12orf65 [107].”
Self-citationD’Aguanno, S., Barassi, A., Lupisella, S., D’Eril, G. M., Boccio, P. D., Pieragostino, D., Pallotti, F., Carelli, V., Valentino, M. L., Liguori, R., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.10.004 · Cited by 30 · cited 1×
“Rightly so, the early focus has been on the molecular genetics, but now there is an urgent need to capitalise on the greater availability of more sophisticated technological platforms to compare the transcriptomic, proteomic and metabolomic profiles between different phenotypic groups to look for potential clues or bi…”
BackgroundSelf-citationHeidary, G., Calderwood, L., Cox, G. F., Robson, C. D., Teot, L. A., Mullon, J., & Anselm, I. A. (2013) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000076 · Cited by 29 · cited 1×
“It should also be noted that both SLC25A46 and C12orf65 mutations can also result in a much more severe neurodegenerative Leigh-like presentation [11, 64, 69].”
BackgroundDiffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies
Manners, D. N., Rizzo, G., Morgia, C. L., Tonon, C., Testa, C. M., Barboni, P., Malucelli, E., Valentino, M. L., Caporali, L., Strobbe, D., et al. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4272 · Cited by 29 · cited 2×
“MRI tractography studies indicate that the loss of RGCs in the anterior visual pathway could result in transsynaptic degeneration that extends from the lateral geniculate nucleus to the optic radiations, as reported previously in other optic neuropathies such as demyelinating optic neuritis and glaucoma [22, 89].”
BackgroundSelf-citationLevin, L. A. (2015) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000250 · Cited by 28 · cited 2×
“It must be emphasised that there is no absolute experimental proof, but the greater surface area/volume ratio in smaller fibres is thought to result in a more limited mitochondrial bioenergetic reserve capacity and proportionally more ROS production compared with larger fibres [83].”
BackgroundMilesi, J., Rocca, M. A., Bianchi‐Marzoli, S., Petrolini, M., Pagani, E., Falini, A., Comı, G., & Filippi, M. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6406-1 · Cited by 28 · cited 1×
“More widespread microstructural white matter changes in mitochondrial optic neuropathies have also become more clearly apparent with the application of high-resolution MRI scanners and diffusion tensor (DT) imaging protocols to study cohorts of patients with LHON and OPA1-related DOA, which is consistent with the know…”
BackgroundDysfunctional mitochondrial maintenance: what breaks the circle of life?
Yu‐Wai‐Man, P., & Chinnery, P. F. (2012) · Brain · doi:10.1093/brain/awr352 · Cited by 27
Self-citationNeuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction
Roubertie, A., Leboucq, N., Picot, M., Nogué, E., Brunel, H., Bars, E. L., Manès, G., Angebault, C., Blanchet, C., Mondain, M., et al. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.01.008 · Cited by 25 · cited 15×
“The overlap between LHON and a multiple sclerosis (MS)-like illness (Harding disease) is a fascinating association that highlights a potential final common pathway linking mitochondrial dysfunction with neuronal loss and disease progression in acquired demyelinating disorders affecting the central nervous system (CNS).”
BackgroundInfluentialTun, A. W., Chaiyarit, S., Kaewsutthi, S., Katanyoo, W., Chuenkongkaew, W. L., Kuwano, M., Tomonaga, T., Peerapittayamongkol, C., Thongboonkerd, V., & Lertrit, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106779 · Cited by 24 · cited 1×
“Rightly so, the early focus has been on the molecular genetics, but now there is an urgent need to capitalise on the greater availability of more sophisticated technological platforms to compare the transcriptomic, proteomic and metabolomic profiles between different phenotypic groups to look for potential clues or bi…”
BackgroundSubclinical multisystem neurologic disease in “pure” OPA1 autosomal dominant optic atrophy
Baker, M. R., Fisher, K. M., Whittaker, R. G., Griffiths, P. G., Yu‐Wai‐Man, P., & Chinnery, P. F. (2011) · Neurology · doi:10.1212/wnl.0b013e318230a15a · Cited by 20 · cited 1×
“The clinical manifestations observed in OPA1 disease have now expanded further to include chronic progressive external ophthalmoplegia (CPEO) and other extraocular features such as ataxia, myopathy and peripheral neuropathy [7, 13, 65].”
BackgroundSelf-citationShiraishi, W., Hayashi, S., Kamada, T., Isobe, N., Yamasaki, R., Murai, H., Ohyagi, Y., & Kira, J. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513513057 · Cited by 20 · cited 3×
“It is, therefore, interesting that in addition to Harding disease, patients with LHON have been described who developed a prominent spinal cord syndrome mimicking the radiological and pathological features of NMO [91, 122].”
BackgroundMyelin, mitochondria, and autoimmunity: What's the connection?
Carelli, V., & Bellan, M. (2008) · Neurology · doi:10.1212/01.wnl.0000307668.75233.35 · Cited by 16 · cited 1×
“Additional research is clearly needed to further explore the interplay between a pathogenic LHON mutation, mitochondrial dysfunction and concurrent white matter CNS demyelinating disease [30, 85].”
BackgroundSelf-citationVisual and psychological morbidity among patients with autosomal dominant optic atrophy
Bailie, M., Votruba, M., Griffiths, P. G., Chinnery, P. F., & Yu‐Wai‐Man, P. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12077 · Cited by 12 · cited 1×
“Unsurprisingly, the risk of blindness ranks high on patients’ fears about the prognosis associated with their specific mitochondrial genetic defect [12, 74].”
BackgroundSelf-citationBrain white matter 1 H MRS in Leber optic neuropathy mutation carriers.
Ostojic, J. N., Jančić, J., Kozic, D. B., Semnic, R. R., Koprivšek, K., Prvulović, M., & Kostić, V. (2009) · PubMed · Cited by 11
Rocca, M. A., Bianchi‐Marzoli, S., Messina, R., Cascavilla, M. L., Zeviani, M., Lamperti, C., Milesi, J., Carta, A., Cammarata, G., Leocani, L., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7696-5 · Cited by 8 · cited 2×
“More widespread microstructural white matter changes in mitochondrial optic neuropathies have also become more clearly apparent with the application of high-resolution MRI scanners and diffusion tensor (DT) imaging protocols to study cohorts of patients with LHON and OPA1-related DOA, which is consistent with the know…”
BackgroundIdebenone treatment in Leber's hereditary optic neuropathy: rationale and efficacy
Gueven, N., & Faldu, D. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.772894 · Cited by 5 · cited 3×
“The latter are essential components of aconitase and the mitochondrial respiratory chain complexes I, II and III, and their combined dysfunction probably contributes to the development of optic neuropathy, which is now a well-recognised feature of FRDA [51].”
BackgroundInfluentialCarelli, V., Ghelli, A. M., Zanna, C., Baracca, A., Sgarbi, G., & Martinuzzi, A. (2004) · Investigative Ophthalmology & Visual Science · Cited by 3
Self-citationCarelli, V., Ghelli, A. M., Baracca, A., Zanna, C., Sgarbi, G., Solaini, G., Lenaz, G., Rugolo, M., & Martinuzzi, A. (2004) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · Cited by 1
Self-citation
Research works printed but not linked: 1
- Sadun AAKY, Wurdeman AE, Dao J, Heller K, Sherman J (1994) Morphological findings in the visual system in a case of Leber’s hereditary optic neuropathy. Clin Neurosci 2:165–172
Cited by
Yu-Wai-Man, P., Newman, N. J., Carelli, V., Moster, M. L., Biousse, V., Sadun, A. A., Klopstock, T., Vignal-Clermont, C., Sergott, R. C., Rudolph, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz7423 · Cited by 232
“11778G>A being the most common mutation worldwide (1, 3, 4).”
BackgroundSelf-citationCarelli, V., Carbonelli, M., de Coo, I. F., Kawasaki, A., Klopstock, T., Lagrèze, W. A., La Morgia, C., Newman, N. J., Orssaud, C., Pott, J. W. R., et al. (2017) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000570 · Cited by 228
“Thinning of the macular RGC layer measured by OCT is largely completed in 4–6 months, highlighting the severe cell loss of the cells originating the papillomacular bundle (8,49).”
BackgroundSelf-citationMitochondrial disease in children
Rahman, S. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13054 · Cited by 178
Newman, N. J., Yu-Wai-Man, P., Carelli, V., Moster, M. L., Biousse, V., Vignal-Clermont, C., Sergott, R. C., Klopstock, T., Sadun, A. A., Barboni, P., et al. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.12.012 · Cited by 168
“11778G>A being the most common mutation worldwide.(1,3) These mutations affect complex I subunits of the mitochondrial respiratory chain, impairing mitochondrial function and increasing the levels of reactive oxygen species.”
BackgroundSelf-citationImpaired complex I repair causes recessive Leber’s hereditary optic neuropathy
Stenton, S. L., Sheremet, N. L., Catarino, C. B., Andreeva, N. A., Assouline, Z., Barboni, P., Barel, O., Berutti, R., Bychkov, I. O., Caporali, L., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138267 · Cited by 163
“The disease arises during young adult life and displays a gender dependent incomplete penetrance of 50% in males and 10% in females (3), resulting in five times more males being affected.”
BackgroundSelf-citation
Metadata
- Authors
- Yu-Wai-Man, P., Votruba, M., Burté, F., La Morgia, C., Barboni, P., & Carelli, V.
- Affiliations
- University Hospital of Wales (GB)
- Wellcome Centre for Mitochondrial Research (GB)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Acta Neuropathologica
- Published
- 2016-09-30
- Volume
- 132
- Issue
- 6
- Pages
- 789-806
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC5106504
- OpenAlex
- W2526582958
- Cited by
- 176
- References
- 150
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 17 · 2023: 15 · 2022: 27 · 2021: 22 · 2020: 25 · 2019: 12 · 2018: 15 · 2017: 15 · 2016: 2
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Medical Research Council (G1002570)
- National Institute for Health Research
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- mitochondrial optic neuropathy, Leber's hereditary optic neuropathy, autosomal dominant optic atrophy, OPA1, mitochondrial DNA mutations, retinal ganglion cell death, papillomacular bundle, melanopsin, neurodegeneration, mitochondrial dysfunction, disease-modifying therapy, genetic engineering, drug delivery
- MeSH terms
- Animals, DNA, Mitochondrial, Humans, Optic Atrophy, Autosomal Dominant, Optic Atrophy, Hereditary, Leber
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.